世界のヒトVEGF抗体市場2020-2025:兎、鼠、山羊、その他

LP Informationが発行した調査報告書(LPI20OC1965)
◆英語タイトル:Global Human VEGF Antibody Market Growth 2020-2025
◆商品コード:LPI20OC1965
◆発行会社(リサーチ会社):LP Information
◆発行日:2020年10月2日(※2024年版があります。お問い合わせください。)
◆ページ数:182
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「ヒトVEGF抗体の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、兎、鼠、山羊、その他など、用途別には、自動車・航空宇宙、機器、石油・ガス、一般産業、その他などに区分してまとめた調査レポートです。ヒトVEGF抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ヒトVEGF抗体の世界市場概要(サマリー)
・ヒトVEGF抗体の企業別販売量・売上
・ヒトVEGF抗体の企業別市場シェア
・ヒトVEGF抗体の世界市場規模 2015年-2020年:種類別(兎、鼠、山羊、その他)
・ヒトVEGF抗体の世界市場規模 2015年-2020年:用途別(自動車・航空宇宙、機器、石油・ガス、一般産業、その他)
・ヒトVEGF抗体の米州市場規模(アメリカ、カナダ、メキシコなど)
・ヒトVEGF抗体のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ヒトVEGF抗体の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトVEGF抗体の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトVEGF抗体市場の成長要因・課題・動向
・ヒトVEGF抗体の世界市場予測 2021年-2025年
・ヒトVEGF抗体の米州市場予測(アメリカ、カナダ、メキシコなど)
・ヒトVEGF抗体のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ヒトVEGF抗体の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ヒトVEGF抗体の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ヒトVEGF抗体の世界市場予測:種類別(兎、鼠、山羊、その他)
・ヒトVEGF抗体の世界市場予測:用途別(自動車・航空宇宙、機器、石油・ガス、一般産業、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Human VEGF Antibody market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human VEGF Antibody business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Human VEGF Antibody market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Human VEGF Antibody, covering the supply chain analysis, impact assessment to the Human VEGF Antibody market size growth rate in several scenarios, and the measures to be undertaken by Human VEGF Antibody companies in response to the COVID-19 epidemic.

Segmentation by host spices: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Rabbit
Mouse
Goat
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Laboratory
Hospital
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
LifeSpan Biosciences
MilliporeSigma
Abcam
R&D Systems
Santa Cruz Biotechnology
ImmunoStar
Novus Biologicals
OriGene
Abnova
Boster
Creative Biomart
ProMab
Sino Biological
Rockland Immunochemicals
BioLegend
Bon Opus Biosciences
Agrisera
Bio-Rad
Enzo Life Sciences
US Biological
Absolute Antibody

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Human VEGF Antibody consumption (value & volume) by key regions/countries, host spices and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human VEGF Antibody market by identifying its various subsegments.
Focuses on the key global Human VEGF Antibody manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human VEGF Antibody with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human VEGF Antibody submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human VEGF Antibody Consumption 2015-2025
2.1.2 Human VEGF Antibody Consumption CAGR by Region
2.2 Human VEGF Antibody Segment by Host Spices
2.2.1 Rabbit
2.2.2 Mouse
2.2.3 Goat
2.2.4 Others
2.3 Human VEGF Antibody Consumption by Host Spices
2.3.1 Global Human VEGF Antibody Consumption Market Share by Host Spices (2015-2020)
2.3.2 Global Human VEGF Antibody Revenue and Market Share by Host Spices (2015-2020)
2.3.3 Global Human VEGF Antibody Sale Price by Host Spices (2015-2020)
2.4 Human VEGF Antibody Segment by Application
2.4.1 Laboratory
2.4.2 Hospital
2.4.3 Others
2.5 Human VEGF Antibody Consumption by Application
2.5.1 Global Human VEGF Antibody Consumption Market Share by Host Spices (2015-2020)
2.5.2 Global Human VEGF Antibody Value and Market Share by Host Spices (2015-2020)
2.5.3 Global Human VEGF Antibody Sale Price by Host Spices (2015-2020)

3 Global Human VEGF Antibody by Company
3.1 Global Human VEGF Antibody Sales Market Share by Company
3.1.1 Global Human VEGF Antibody Sales by Company (2018-2020)
3.1.2 Global Human VEGF Antibody Sales Market Share by Company (2018-2020)
3.2 Global Human VEGF Antibody Revenue Market Share by Company
3.2.1 Global Human VEGF Antibody Revenue by Company (2018-2020)
3.2.2 Global Human VEGF Antibody Revenue Market Share by Company (2018-2020)
3.3 Global Human VEGF Antibody Sale Price by Company
3.4 Global Human VEGF Antibody Manufacturing Base Distribution, Sales Area, Host Spices by Company
3.4.1 Global Human VEGF Antibody Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human VEGF Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human VEGF Antibody by Regions
4.1 Human VEGF Antibody by Regions
4.2 Americas Human VEGF Antibody Consumption Growth
4.3 APAC Human VEGF Antibody Consumption Growth
4.4 Europe Human VEGF Antibody Consumption Growth
4.5 Middle East & Africa Human VEGF Antibody Consumption Growth

5 Americas
5.1 Americas Human VEGF Antibody Consumption by Countries
5.1.1 Americas Human VEGF Antibody Consumption by Countries (2015-2020)
5.1.2 Americas Human VEGF Antibody Value by Countries (2015-2020)
5.2 Americas Human VEGF Antibody Consumption by Host Spices
5.3 Americas Human VEGF Antibody Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human VEGF Antibody Consumption by Regions
6.1.1 APAC Human VEGF Antibody Consumption by Regions (2015-2020)
6.1.2 APAC Human VEGF Antibody Value by Regions (2015-2020)
6.2 APAC Human VEGF Antibody Consumption by Host Spices
6.3 APAC Human VEGF Antibody Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Human VEGF Antibody by Countries
7.1.1 Europe Human VEGF Antibody Consumption by Countries (2015-2020)
7.1.2 Europe Human VEGF Antibody Value by Countries (2015-2020)
7.2 Europe Human VEGF Antibody Consumption by Host Spices
7.3 Europe Human VEGF Antibody Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Human VEGF Antibody by Countries
8.1.1 Middle East & Africa Human VEGF Antibody Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human VEGF Antibody Value by Countries (2015-2020)
8.2 Middle East & Africa Human VEGF Antibody Consumption by Host Spices
8.3 Middle East & Africa Human VEGF Antibody Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human VEGF Antibody Distributors
10.3 Human VEGF Antibody Customer

11 Global Human VEGF Antibody Market Forecast
11.1 Global Human VEGF Antibody Consumption Forecast (2021-2025)
11.2 Global Human VEGF Antibody Forecast by Regions
11.2.1 Global Human VEGF Antibody Forecast by Regions (2021-2025)
11.2.2 Global Human VEGF Antibody Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human VEGF Antibody Forecast by Host Spices
11.8 Global Human VEGF Antibody Forecast by Application

12 Key Players Analysis
12.1 Thermo Fisher
12.1.1 Company Information
12.1.2 Human VEGF Antibody Product Offered
12.1.3 Thermo Fisher Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Latest Developments
12.2 LifeSpan Biosciences
12.2.1 Company Information
12.2.2 Human VEGF Antibody Product Offered
12.2.3 LifeSpan Biosciences Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 LifeSpan Biosciences Latest Developments
12.3 MilliporeSigma
12.3.1 Company Information
12.3.2 Human VEGF Antibody Product Offered
12.3.3 MilliporeSigma Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 MilliporeSigma Latest Developments
12.4 Abcam
12.4.1 Company Information
12.4.2 Human VEGF Antibody Product Offered
12.4.3 Abcam Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Abcam Latest Developments
12.5 R&D Systems
12.5.1 Company Information
12.5.2 Human VEGF Antibody Product Offered
12.5.3 R&D Systems Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 R&D Systems Latest Developments
12.6 Santa Cruz Biotechnology
12.6.1 Company Information
12.6.2 Human VEGF Antibody Product Offered
12.6.3 Santa Cruz Biotechnology Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Santa Cruz Biotechnology Latest Developments
12.7 ImmunoStar
12.7.1 Company Information
12.7.2 Human VEGF Antibody Product Offered
12.7.3 ImmunoStar Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 ImmunoStar Latest Developments
12.8 Novus Biologicals
12.8.1 Company Information
12.8.2 Human VEGF Antibody Product Offered
12.8.3 Novus Biologicals Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novus Biologicals Latest Developments
12.9 OriGene
12.9.1 Company Information
12.9.2 Human VEGF Antibody Product Offered
12.9.3 OriGene Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 OriGene Latest Developments
12.10 Abnova
12.10.1 Company Information
12.10.2 Human VEGF Antibody Product Offered
12.10.3 Abnova Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Abnova Latest Developments
12.11 Boster
12.11.1 Company Information
12.11.2 Human VEGF Antibody Product Offered
12.11.3 Boster Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Boster Latest Developments
12.12 Creative Biomart
12.12.1 Company Information
12.12.2 Human VEGF Antibody Product Offered
12.12.3 Creative Biomart Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Creative Biomart Latest Developments
12.13 ProMab
12.13.1 Company Information
12.13.2 Human VEGF Antibody Product Offered
12.13.3 ProMab Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 ProMab Latest Developments
12.14 Sino Biological
12.14.1 Company Information
12.14.2 Human VEGF Antibody Product Offered
12.14.3 Sino Biological Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Sino Biological Latest Developments
12.15 Rockland Immunochemicals
12.15.1 Company Information
12.15.2 Human VEGF Antibody Product Offered
12.15.3 Rockland Immunochemicals Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Rockland Immunochemicals Latest Developments
12.16 BioLegend
12.16.1 Company Information
12.16.2 Human VEGF Antibody Product Offered
12.16.3 BioLegend Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 BioLegend Latest Developments
12.17 Bon Opus Biosciences
12.17.1 Company Information
12.17.2 Human VEGF Antibody Product Offered
12.17.3 Bon Opus Biosciences Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Bon Opus Biosciences Latest Developments
12.18 Agrisera
12.18.1 Company Information
12.18.2 Human VEGF Antibody Product Offered
12.18.3 Agrisera Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Agrisera Latest Developments
12.19 Bio-Rad
12.19.1 Company Information
12.19.2 Human VEGF Antibody Product Offered
12.19.3 Bio-Rad Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Bio-Rad Latest Developments
12.20 Enzo Life Sciences
12.20.1 Company Information
12.20.2 Human VEGF Antibody Product Offered
12.20.3 Enzo Life Sciences Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Enzo Life Sciences Latest Developments
12.21 US Biological
12.21.1 Company Information
12.21.2 Human VEGF Antibody Product Offered
12.21.3 US Biological Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 US Biological Latest Developments
12.22 Absolute Antibody
12.22.1 Company Information
12.22.2 Human VEGF Antibody Product Offered
12.22.3 Absolute Antibody Human VEGF Antibody Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Absolute Antibody Latest Developments

13 Research Findings and Conclusion

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のヒトVEGF抗体市場2020-2025:兎、鼠、山羊、その他(Global Human VEGF Antibody Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。